Men With Prostate Cancer Increasingly Don't Die From It

This article originally appeared here.
Men With Prostate Cancer Increasingly Don't Die From It
Men With Prostate Cancer Increasingly Don't Die From It

(HealthDay News) -- Men diagnosed with prostate cancer are more likely to die from other conditions, including heart disease, than from prostate cancer, according to a study published online July 25 in the Journal of the National Cancer Institute.

Mara M. Epstein, Sc.D., from the Harvard School of Public Health in Boston, and colleagues used data from the Swedish Cancer Registry (1961 to 2008; 210,112 patients) and from the U.S. Surveillance, Epidemiology, and End Results Program (1973 to 2008; 490,341 patients) to analyze causes of death among all incident prostate cancer cases.

The researchers found that, during follow-up through 2008, prostate cancer accounted for 52 and 30 percent of all reported deaths in the Swedish and U.S. prostate cancer cohorts, respectively, which corresponded to 35 and 16 percent, of those diagnosed with prostate cancer who died from the disease. The cumulative incidence of prostate cancer-specific death decreased during follow-up in both populations, while the cumulative incidences of death from ischemic heart disease and non-prostate cancer remained constant. In Sweden and the United States, the five-year cumulative incidence of death from prostate cancer was 29 and 11 percent, respectively.

"Managing prostate cancer patients with a lifestyle approach could increase the duration and quality of life among men living with prostate cancer, arguably more than aggressive treatment, by addressing increasingly dominant, yet preventable, causes of death," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs